A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Post-Conference Report Provides HIV Cure Roadmap
Life Expectancy With HIV Increases Dramatically
Improper Use of a Neti Pot Can Be Fatal
Animal Studies Suggest Anti-Reservoir Drugs May Help 'Functionally Cure' HIV
Tenofovir Microbicide Gel Falters in Major HIV Prevention Study
Gold Drug Shows HIV Eradication Potential
New Studies Under Way of Sangamo's Possible 'Functional Cure' Gene Therapy
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

August 27, 2007

Marijuana or Marinol? Both Show Benefits

HIV-positive people have long smoked marijuana or taken its synthetic counterpart Marinol (dronabinol) to maintain their appetites and keep weight on. A new study, conducted at the New York State Psychiatric Institute and reported in the August 15 issue of the Journal of Acquired Immune Deficiency Syndromes, suggest that both drugs are equally effective for these purposes.

The study admitted 10 HIV-positive patients to the Institute, where they alternated between smoking marijuana and taking Marinol—both containing different amounts of THC, the active ingredient in both drugs—for a total of 32 days, with periods of placebo use between the periods of active drug use.

Along with their comparable increases in munchies and body weight, both drugs produced significant intoxication, except for low-dose Marinol (5 mg). Measures of cognitive ability, such as memory testing, were no better or worse on THC-administration days compared to placebo days. Sleep scores, including estimated sleep time, were significantly higher on the days of smoking pot with the highest concentraion of THC.

emailrssprint


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    jakeinps
    Desert Cities
    California


    zachowell86
    Birmingham
    Alabama


    second2none
    Seattle
    Washington


    flowrider
    Dallas
    Texas
Click here to join POZ Personals!
Conference Coverage

6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


XVIII International AIDS Conference
Vienna, Austria
July 18-23, 2010

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.